-
Signature
-
/s/ Christopher Bedi by Russell S. Elmer, Attorney-in-Fact
-
Stock symbol
-
NOW
-
Transactions as of
-
Aug 11, 2023
-
Transactions value $
-
-$467,761
-
Form type
-
4
-
Date filed
-
8/15/2023, 04:22 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
NOW |
Common Stock |
Options Exercise |
$0 |
+1.13K |
+7.57% |
$0.00 |
16K |
Aug 11, 2023 |
Direct |
|
transaction |
NOW |
Common Stock |
Tax liability |
-$312K |
-560 |
-3.49% |
$557.44 |
15.5K |
Aug 11, 2023 |
Direct |
F1 |
transaction |
NOW |
Common Stock |
Options Exercise |
$0 |
+136 |
+0.88% |
$0.00 |
15.6K |
Aug 11, 2023 |
Direct |
|
transaction |
NOW |
Common Stock |
Tax liability |
-$37.9K |
-68 |
-0.44% |
$557.44 |
15.6K |
Aug 11, 2023 |
Direct |
F1 |
transaction |
NOW |
Common Stock |
Sale |
-$118K |
-213 |
-1.37% |
$552.53 |
15.3K |
Aug 14, 2023 |
Direct |
F2 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
NOW |
Restricted Stock Units |
Options Exercise |
$0 |
-1.13K |
-21.43% |
$0.00 |
4.14K |
Aug 11, 2023 |
Common Stock |
1.13K |
|
Direct |
F3, F4, F5 |
transaction |
NOW |
Restricted Stock Units |
Options Exercise |
$0 |
-136 |
-9.06% |
$0.00 |
1.37K |
Aug 11, 2023 |
Common Stock |
136 |
|
Direct |
F3, F6 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: